TABLE 2. Demographic Characteristics by Response to Therapy (STUDY 2).
Covariate (frequency or median, range) | SVR n = 32 (55%) | No SVR n = 26 (45%) | P value |
---|---|---|---|
Gender (Male) | (n=17) 53% | (n=15) 58% | 0.72 |
Age (yr) | 12.8 (7.2 –18.3) | 13.0 (5.9 – 19.2) | 0.94 |
Infection Duration (yr) | 12.3 (0.6 – 18) | 10.7 (2.8 – 19.2) | 0.86 |
Genotypes | 1 (n=20) 63% | 1 (n=25) 96% | 0.004† |
2 (n=6) | 2 (n=1) | ||
3 (n=5) | |||
4 (n=1) | |||
Overweight (BMI >85%ile) | (n=6) 19% | (n=11) 42% | 0.05 |
Testing frequency of genotype 1. SVR, sustained virologic response;